Stempeutics signed a co-development agreement with Alkem...
Stempeutics partners with Cipla to create greater access to stem cell medicines...
We want to solve unmet medical needs...
Lead the change...
Stempeutics receives orphan drug designation
Stempeutics Research granted process patent in China
Careers in new-age biological avenues
Cipla JV firm's drug gets OD status
Stempeutics' Stempeucel gets Orphan Drug status
Stempeutics gets Japanese process patent for stem cell drug
Stempeutics eyes late-stage trial waiver for stem-cell drug
Stem cell Research Making Strides in India
Stempeutics plans stem cell device launch in india by mid 2016
Stempeutics receives japan process patent for its novel stem cell drug stempeucel®
Stempeutics - MoneyControl"
Stempeutics planning the launch of stem cell device in India by mid
City based Drug Maker Stempeutics Headed to Europe
Liver Cirrhosis therapeutic pipeline h2 2014 review research
Stempeutics receives US process patent (8,956,862) for its novel stem cell drug "Stempeucel®"
More stem cell therapies to be launched in next five years
Stem Cells Industry: The Battle Within
Stem cell therapy market
Stempeutics has been mentioned in a SCSI quantitative analysis on industry sponsored stem cell clinical trials. Stempeutics is represented in the top 7 companies.
Startups do promising work in drug development, stem cell therapy and advanced diagnostics
Made-in-India Medical Tech Saves Lives Across Borders.
Stem cell-based drug holds hope
Stempeutics to launch its stem cell based new drug in India by 2013/2014
A Leading Indian Stem Cell Company Developing Cellular Therapeutics for Global Consumers
Push Stem Cell Research to Help Mankind - BN Manohar
Trial and triumph -
A country-wide clinical trial of a stem cell based therapy may become the benchmark for such trials in future
India's first stem cell trail to take place in City.
Miracles of Science in Regenerative Medicine .
Stempeutics gets Malaysian Regulatory approval for conducting Clinical Trials in Malaysia.
Stempeutics announces clinical trial outcome of India's FIRST stem cell product.
Stempeutics gets DCGI nod to start Phase II clinical trial for four debilitating diseases.
Stempeutics launches FIRST Human Stem Cell Clinical Trial in Malaysia for Cerebral Stroke using GMP certified facility at Kuala Lumpur.
Stempeutics receives DCGI clearance to start human clinical trial of its Investigational New Drug for Acute Myocardial Infarction (AMI) and Critical Limb Ischemia (CLI)..
Stempeutics Research Malaysia was inaugurated by Yang Berhormat Tuan Haji Fadilah Yusof – Deputy Minister of Science, Technology and Innovation, Malaysia.
We plan to bring out innovative tailor - made cells for diseases.
Stempeutics Research Manipal has been awarded ISO 9001:2008 certification for "Development and Processing of Stem Cells for Clinical Trials" by TUV Rheinlando.
Stempeutics has entered into a strategic alliance with Cipla.